- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02505594
Potential Mechanism of Exercise Impairment in OSA
Pulmonary Vasoreactivity as a Potential Mechanism of Exercise Impairment in Obstructive Sleep Apnea
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
Obstructive sleep apnea (OSA) is a common disorder with major cardiovascular sequelae, including increased systemic hypertension and strokes. OSA is highly prevalent among patients with cardiovascular disease (CVD), but OSA remains under-diagnosed, thus under-treated. Furthermore, a recent study confirmed that OSA is associated with impaired exercise capacity and increasing OSA severity predicts worsening exercise capacity, which is a marker of potential increased cardiovascular risk. However, potential mechanisms of decreased exercise capacity caused by OSA remain unclear.
Several pathophysiologic mechanisms of OSA have been proposed to explain this observation. Endothelial dysfunction is one mechanism that may result from OSA-related intermittent hypoxemia, heightened sympathetic activation, and increased blood pressure. Endothelial dysfunction is characterized by alteration of normal endothelial physiology consisting of a reduction in the bioavailability of vasodilators such as nitric oxide leading to impaired endothelium-depended vasodilation. Endothelial dysfunction has been consistently associated with an increased incidence of CVD. Recent evidence also suggests a correlation between endothelial function and exercise capacity.
In addition, endothelial dysfunction of pulmonary vasculature play an integral role in the pathogenesis of pulmonary hypertension (PH), which is defined by a mean pulmonary artery pressure exceeding 25 mm Hg. PH is associated with increased mortality and multiple morbidities including impaired exercise capacity. OSA has been formally recognized as a cause of PH by the World Health Organization (WHO) and the estimated prevalence of PH in patients with OSA is 17%. Repetitive nocturnal hypoxemia, increased sympathetic tone, and diminished endothelial dependent vaso-reactivity contribute to pulmonary artery hypoxic vasoconstriction, subsequently leading to pulmonary vasculature remodeling and PH. Recently, PH induced by exercise was described as part of the PH spectrum and may represent early, mild, PH that is still clinically relevant in many patients. To detect early PH in OSA patients may signify the importance of treatment and compliance for newly diagnosed OSA patients.
In summary, our hypothesis is that OSA patients may have endothelial dysfunction that leads to impaired exercise capacity via exercise-induced pulmonary hypertension. If our hypothesis is correct, non-invasive measurements of endothelial function could be used clinically to risk stratify patients or follow response to treatment.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
California
-
San Diego, California, Förenta staterna, 92093
- University of California, San Diego
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- BMI < 30
- OSA group: diagnosis of untreated moderate-to-severe OSA (apnea-hypopnea index (AHI) ≥ 15 events/h).
- Control group: no OSA (AHI < 5 events/h).
Exclusion Criteria:
- Currently using Continuous Positive Airway Pressure (CPAP) or oral appliance treatment for OSA
- Uncontrolled cardiac co-morbidity, e.g. ischemic heart disease, heart failure, or valvular heart disease that would prevent exercise
- Uncontrolled pulmonary co-morbidity, e.g. asthma or chronic obstructive pulmonary disease (COPD)
- Comorbidities that may severely impair peripheral circulation, e.g. uncontrolled diabetes mellitus, or systemic scleroderma
- Neurological conditions limiting the ability to perform walking or cycling
- Orthopedic condition limiting the ability to perform walking or cycling
- Current smokers, alcohol (> 3 oz/day) or use of illicit drugs.
- Psychiatric disorder, other than mild and controlled depression; e.g. schizophrenia, bipolar disorder, major depression, panic or anxiety disorders.
- Pregnancy
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
---|
OSA Group
Apnea-hypopnea index (AHI) ≥ 15 events/h
|
Control Group
Apnea-hypopnea index (AHI) < 5 events/h
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Endothelial function, as measured by endoPAT, between OSA patients and matched healthy controls
Tidsram: Baseline
|
EndoPAT is a non-invasive measurement of endothelial function, using peripheral arterial tonometry.
Exercise tolerance is measured by Cardiopulmonary exercise testing (CPET).
Effects of OSA on exercise tolerance and endothelial function will be evaluated.
|
Baseline
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Right ventricular systolic pressure (RVSP) in response to exercise
Tidsram: Baseline
|
Measured by Echocardiogram, between OSA patients and matched healthy controls
|
Baseline
|
Pulmonary systolic pressure (PASP) in response to exercise
Tidsram: Baseline
|
Measured by Echocardiogram, between OSA patients and matched healthy controls
|
Baseline
|
Right ventricular outflow track (RVOT) peak velocity in response to exercise
Tidsram: Baseline
|
Measured by Echocardiogram, between OSA patients and matched healthy controls
|
Baseline
|
Velocity time interval (VTI) in response to exercise
Tidsram: Baseline
|
Measured by Echocardiogram, between OSA patients and matched healthy controls
|
Baseline
|
Pulmonary artery acceleration time in response to exercise
Tidsram: Baseline
|
Measured by Echocardiogram, between OSA patients and matched healthy controls
|
Baseline
|
Systolic peak tricuspid myocardial annular velocity
Tidsram: Baseline
|
Measured by Echocardiogram, between OSA patients and matched healthy controls
|
Baseline
|
Diastolic peak tricuspid myocardial annular velocity
Tidsram: Baseline
|
Measured by Echocardiogram, between OSA patients and matched healthy controls
|
Baseline
|
Peak tricuspid myocardial annular velocity during isovolumic contraction
Tidsram: Baseline
|
Measured by Echocardiogram, between OSA patients and matched healthy controls
|
Baseline
|
Peak tricuspid myocardial annular velocity during isovolumic relaxation
Tidsram: Baseline
|
Measured by Echocardiogram, between OSA patients and matched healthy controls
|
Baseline
|
Right ventricular (RV) wall stress
Tidsram: Baseline
|
Measured by Echocardiogram, between OSA patients and matched healthy controls
|
Baseline
|
3-D right ventricular ejection fraction (3D-RVEF)
Tidsram: Baseline
|
Measured by Echocardiogram, between OSA patients and matched healthy controls
|
Baseline
|
Systolic peak right ventricular (RV) strain
Tidsram: Baseline
|
Measured by Echocardiogram, between OSA patients and matched healthy controls
|
Baseline
|
Early diastolic peak right ventricular (RV) strain
Tidsram: Baseline
|
Measured by Echocardiogram, between OSA patients and matched healthy controls
|
Baseline
|
Late diastolic peak right ventricular (RV) strain
Tidsram: Baseline
|
Measured by Echocardiogram, between OSA patients and matched healthy controls
|
Baseline
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- UCSD150468
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Obstruktiv sömnapné
-
University of Wisconsin, MadisonPhilips HealthcareAvslutadSömn, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization
-
National University of SingaporeRekryteringReduktion av skärmanvändning + Sleep Extension | FrilevandeSingapore
-
Northwell HealthJazz PharmaceuticalsRekryteringElektrisk status Epilepticus of Slow-Wave SleepFörenta staterna
-
Eisai Inc.AvslutadOregelbunden Sleep Wake Rhythm DisorderFörenta staterna
-
Brigham and Women's HospitalAktiv, inte rekryterandeSömnstörningar, inneboende | Sömnstörningar, dygnsrytm | Advanced Sleep Phase Syndrome (ASPS) | Fördröjd sömnfassyndrom | Shift-Work Sömnstörning | Försenad sömnfas | Icke-24 timmars sömn-vaken störning | Advanced Sleep Phase Syndrome | Avancerad sömnfas | Oregelbundet sömn-vakna syndrom | Skift Arbetstyp Dygnsrytm...Förenta staterna
-
Brigham and Women's HospitalCharite University, Berlin, Germany; Stanford UniversityRekryteringSömnstörningar, inneboende | Vakna sömnstörningar | Sömnstörningar, dygnsrytm | Advanced Sleep Phase Syndrome (ASPS) | Fördröjd sömnfassyndrom | Shift-Work Sömnstörning | Försenad sömnfas | Icke-24 timmars sömn-vaken störning | Advanced Sleep Phase Syndrome | Avancerad sömnfas | Oregelbundet sömn-vakna syndrom | Skift Arbetstyp Dygnsrytm Sömnstörning och andra villkorFörenta staterna
-
Tyco Healthcare GroupOkänd
-
Brigham and Women's HospitalStanford UniversityRekryteringVakna sömnstörningar | Sömnstörning | Sömnstörningar, dygnsrytm | Dygnsrytmstörningar | Circadian Rhythm Sömnstörning | Advanced Sleep Phase Syndrome (ASPS) | Fördröjd sömnfassyndromFörenta staterna
-
Maastricht University Medical CenterEpilepsiecentrum KempenhaegheAvslutadRolandsk epilepsi | Landau-Kleffners syndrom | Nattlig frontallobsepilepsi | Elektrisk status Epilepticus under Slow Wave SleepNederländerna